Torrent Pharmaceuticals Limited - Asset Resilience Ratio

Latest as of March 2026: 1.95%

Torrent Pharmaceuticals Limited (TORNTPHARM) has an Asset Resilience Ratio of 1.95% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Torrent Pharmaceuticals Limited PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

Rs8.66 Billion

≈ $93.65 Million USD Cash + Short-term Investments

Total Assets

Rs443.12 Billion

≈ $4.79 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2007–2026)

This chart shows how Torrent Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. See Torrent Pharmaceuticals Limited balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Torrent Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Torrent Pharmaceuticals Limited market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs8.66 Billion	1.95%
Total Liquid Assets	Rs8.66 Billion	1.95%

Asset Resilience Insights

Limited Liquidity: Torrent Pharmaceuticals Limited maintains only 1.95% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Torrent Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio

Compare Torrent Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	1.28%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	Drug Manufacturers - Specialty & Generic	-0.89%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Xeris Pharmaceuticals Inc NASDAQ:XERS	Drug Manufacturers - Specialty & Generic	0.00%
Procter & Gamble Health Limited NSE:PGHL	Drug Manufacturers - Specialty & Generic	33.01%

Annual Asset Resilience Ratio for Torrent Pharmaceuticals Limited (2007–2026)

The table below shows the annual Asset Resilience Ratio data for Torrent Pharmaceuticals Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	1.95%	Rs8.66 Billion ≈ $93.65 Million	Rs443.12 Billion ≈ $4.79 Billion	-0.35pp
2025-03-31	2.31%	Rs3.46 Billion ≈ $37.42 Million	Rs149.90 Billion ≈ $1.62 Billion	-1.28pp
2024-03-31	3.59%	Rs5.40 Billion ≈ $58.43 Million	Rs150.61 Billion ≈ $1.63 Billion	+1.16pp
2023-03-31	2.43%	Rs3.65 Billion ≈ $39.47 Million	Rs150.12 Billion ≈ $1.62 Billion	+0.85pp
2022-03-31	1.58%	Rs2.07 Billion ≈ $22.43 Million	Rs131.00 Billion ≈ $1.42 Billion	+0.30pp
2021-03-31	1.28%	Rs1.80 Billion ≈ $19.51 Million	Rs140.75 Billion ≈ $1.52 Billion	-0.54pp
2020-03-31	1.83%	Rs2.56 Billion ≈ $27.71 Million	Rs140.38 Billion ≈ $1.52 Billion	-2.55pp
2019-03-31	4.37%	Rs6.17 Billion ≈ $66.75 Million	Rs141.21 Billion ≈ $1.53 Billion	-7.90pp
2018-03-31	12.27%	Rs17.47 Billion ≈ $188.97 Million	Rs142.43 Billion ≈ $1.54 Billion	-7.78pp
2017-03-31	20.05%	Rs20.30 Billion ≈ $219.55 Million	Rs101.25 Billion ≈ $1.09 Billion	+11.62pp
2016-03-31	8.43%	Rs7.60 Billion ≈ $82.22 Million	Rs90.14 Billion ≈ $974.79 Million	+4.67pp
2015-03-31	3.76%	Rs2.98 Billion ≈ $32.18 Million	Rs79.11 Billion ≈ $855.55 Million	+0.10pp
2014-03-31	3.66%	Rs1.86 Billion ≈ $20.08 Million	Rs50.70 Billion ≈ $548.28 Million	+2.06pp
2013-03-31	1.60%	Rs604.40 Million ≈ $6.54 Million	Rs37.83 Billion ≈ $409.10 Million	-1.22pp
2012-03-31	2.81%	Rs865.16 Million ≈ $9.36 Million	Rs30.74 Billion ≈ $332.39 Million	-2.79pp
2011-03-31	5.60%	Rs1.43 Billion ≈ $15.44 Million	Rs25.48 Billion ≈ $275.60 Million	-0.19pp
2010-03-31	5.79%	Rs1.14 Billion ≈ $12.31 Million	Rs19.65 Billion ≈ $212.52 Million	-3.68pp
2009-03-31	9.47%	Rs1.58 Billion ≈ $17.07 Million	Rs16.67 Billion ≈ $180.33 Million	+3.45pp
2008-03-31	6.01%	Rs760.99 Million ≈ $8.23 Million	Rs12.66 Billion ≈ $136.90 Million	+0.91pp
2007-03-31	5.11%	Rs533.55 Million ≈ $5.77 Million	Rs10.45 Billion ≈ $113.01 Million	--

pp = percentage points

About Torrent Pharmaceuticals Limited

NSE:TORNTPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$16.35 Billion

Rs1.51 Trillion INR

Market Cap Rank

#1541 Global

#49 in India

Share Price

Rs4466.70

Change (1 day)

-0.83%

52-Week Range

Rs3164.00 - Rs4572.60

All Time High

Rs4572.60